Sample Report | Old Report | Not Current

AWE (ASX:AWE) Share Analysis and Stock Report

AWE
February 13, 2018 FAT-AUS-859
Speculative
high
H

CERCG persists as Mitsui sets the date

China Energy Reserve and Chemical Australia (CERCG) has now lodged a supplementary Bidders Statement in support of its offer to acquire AWE (ASX:AWE). In the meantime, Mitsui & Co (Mitsui), a late entrant into the AWE battle has set the record date to determine those AWE shareholders who will receive the documentation pertinent to its takeover offer. But wait the market is now bidding A97.5 cents.

CERCG was directed by the Australian Government Takeover Panel (TVO) that it had to lodge a supplementary Bidders Statement.  The TVO gave the directive to address deficiencies in CERCG’s original document. CERCG has complied with the directive and has now lodged a supplementary Bidders Statement.

The CERCG bid for AWE (ASX:AWE) stands at A73 cents cash per share, which is substantially lower than the A95 cents cash per share on offer from Mitsui. The CERCG bid has been rejected by the AWE Board on the grounds of a higher bid becoming available.

Members who hold AWE (ASX:AWE) shares and on receipt of the CERCG Bidders Statement should take no action.

Meanwhile, Mitsui has set the record date to determine those AWE shareholders that will receive its Bibbers Statement that contains the details of its offer to acquire AWE. Members who held AWE shares in their portfolio on 9 February 2018 will receive the relevant documentation from Mitsui. The Mitsui bid stands at A95 cents cash per share and will close on 23 Mach 2018. The AWE Board has recommended the Mitsui bid in the absence of any higher bid.

A further suitor for AWE (ASX:AWE) in Mineral Resources has not advanced its offer at this stage.

The cash and scrip offer values AWE at around A80 to A85 cents per share. The AWE Board has rejected the Mineral resources bid on the grounds of higher bid becoming available. No action is required at this time regarding the Mineral Resources bid.

AWE (ASX:AWE) Share Price Chart

Turning to the daily chart, overhead resistance is sighted at the January high of $1.00 (psychological whole number) as marked by the horizontal red line. However, it should be noted that the rapid increase in share price following the takeover offers has resulted in the RSI to ascend, and is currently within range of overbought territory (exhaustion of short-term upward momentum). Hence, should the bears emerge over the near-term, a temporary pullback in price could follow. Positively, should this occur, we would view this short-term pause as both corrective and healthy. Medium-term momentum remains in favour of the bulls, as backed by the bullish moving average crossover present since November 2017. This occurs when the 50-day moving average (red line) crosses above the 200-day moving average (green line).

AWE (ASX:AWE) Share Price Chart

With reference to the monthly chart, our previously defined structural resistance region at the $0.95 mark as shown by the horizontal dashed-red line was recently cleared in January. This is a significant price point as it offered firm support in September 2011, after the deep sell-off which took place after prices reached an all-time high of $4.35 in May 2008. For this reason, we would expect upward momentum to rise, and a medium-term upward trajectory in the share price towards resistance sighted between $1.15 and $1.35 to be on the horizon. This is made up of the 50% and 61.8% Fibonacci retracement levels respectively. A definitive break above this price range would likely steer the broader direction of AWE, moving forward.

Members who hold AWE (ASX:AWE) shares are not required to take any action regarding the Mitsui bid on receipt of its Bibbers Statement.

We will advise Members of an appropriate course of action closer to the close date for the Mitsui bid being 23 March 2018.

At the time of writing, AWE (ASX:AWE) shares were trading at A97.5 cents, which indicates the market is speculating on a higher bid for AWE (ASX:AWE) being made and we will continue to monitor events closely.

For Fat Prophets’ current equity research and membership options, visit our Products page.

About this archived stock report

This is an archived Fat Prophets equity research stock report and share analysis. It does not constitute current investment advice, financial product advice, or a recommendation to buy, sell or hold any financial product. It is provided for historical reference only, and reflects the market conditions, company information, forecasts and opinions available at its original publication date. The information may no longer be current or applicable. Past performance is not a reliable indicator of future performance. This is general information only and does not take into account your objectives, financial situation or needs. Before acting on anything in this report, you should consider its appropriateness to your circumstances and seek advice from a licensed financial adviser.

DISCLAIMER Fat Prophets has made every effort to ensure the reliability of the views and recommendations expressed in the reports published on its websites. Fat Prophets research is based upon information known to us or which was obtained from sources which we believed to be reliable and accurate at time of publication. However, like the markets, we are not perfect. This report is prepared for general information only, and as such, the specific needs, investment objectives or financial situation of any particular user have not been taken into consideration. Individuals should therefore discuss, with their financial planner or advisor, the merits of each recommendation for their own specific circumstances and realise that not all investments will be appropriate for all subscribers. To the extent permitted by law, Fat Prophets and its employees, agents and authorised representatives exclude all liability for any loss or damage (including indirect, special, or consequential loss or damage) arising from the use of, or reliance on, any information within the report whether or not caused by any negligent act or omission. If the law prohibits the exclusion of such liability, Fat Prophets hereby limits its liability, to the extent permitted by law, to the resupply of the said information or the cost of the said resupply.

Funds Management – In addition to the listed fund FPC, Fat Prophets Pty Ltd manages the separately managed accounts, namely Concentrated Australian Shares, Australian Shares Income, Small Midcap, Global Opportunities, Mining & Resources, and Asian Shares. These SMAs are managed under their own mandates by the fund managers, and this is independent to the research reports.

Staff trading – Fat Prophets Pty Ltd, its directors, employees and associates of Fat Prophets may hold interests in many ASX-listed Australian companies which may or may not be mentioned or recommended in the Fat Prophets newsletter. These positions may change at any time, without notice. To manage the conflict between personal dealing and newsletter recommendations the directors, employees, and associates of Fat Prophets Pty Ltd cannot knowingly trade in a stock 48 hours either side of a buy or sell recommendation being made in the Fat Prophets newsletter. Staff trades are pre-approved by an appointed staff trading compliance officer to ensure compliance with the staff trading policy.

For positions that directors and/or associates of the Fat Prophets group of companies currently hold in, please click here.

Fat Prophets Logo

Stock Disclosure

ASX- Listed Australian Stocks:
29M.AU, ANN.AU, ANZ.AU, BPT.AU, BWP.AU, CKF.AU, CBA.AU, EVN.AU, FID.AU, FMG.AU, GOR.AU, GMG.AU, GNC.AU, HUB.AU, ILU.AU, IGO.AU, JHX.AU, MGR.AU, NAB.AU, PAR.AU, QBE.AU, RRL.AU, S32.AU, SBM.AU, TLS.AU, TUA.AU, WES.AU, WBC.AU, WHC.AU, XRO.AUX, AGL.AX, AMC.AX, BHP.AX, CSL.AX, DMP.AX, GDG.AX, WIRE.AX, ATOM.AX, MQG.AX, NIC.AX, NST.AX, ORI.AX, PDN.AX, RMS.AX, RPL.AX, SFR.AX, STO.AX, SUN.AX, VAU.AX, WTC.AX, WDS.AX, GMD.AX, CSC.AX, RIO.AX, GTK.AX, SPK.AX & NEM.AX

International Stocks:
BIDU.CN, 9888.CN, 1211.CN, 268.CN, 3690.HK, 1818.HK, 9618.CN, ENX.FR, BT.A.GB, GENI.GB, FRES.GB, 9988.HK, 2282.HK, 700.HK, 1128.HK, 1876.HK, 8750, 7011.T, 8306.JP, 8031.T, 8411.T, 3994.T, 7974.T, 8604.JP, 8308, 6758.JP, 8316.JP, 8331.T, JP.8308, HEM.SE, GRAB.SG, BABA.K, GOOG.US, AAPL.US, CDE.US, CPNG.K, FLTRF.L, SIL, URA, BZ.O, MSFT.US, SBSW.K, 2840.HK, TME, GDX, GDXJ.US, YUMC.K, Z.O, IMPUY & ANGPY